My Retina Tracker® Panel
A comprehensive 110-gene panel designed to identify pathogenic variants associated with inherited retinal degenerations and related retinal dystrophies.
Accessed through the My Retina Tracker® Sponsored Testing Program•Sponsored by Foundation Fighting Blindness•Performed by Prevention Genetics
Designed to support clinical decision-making and ordering in your practice.
For healthcare providers
Overview
This program offers no-cost 110-gene panel testing for patients with a clinically confirmed inherited retinal disease (IRD). Testing supports molecular diagnosis, guides management decisions, and helps identify individuals who may qualify for targeted therapies or clinical research. Eligible patients must enroll through the Program workflow and complete all required consent and HIPAA documentation.
When to consider this test
Patient selection
- Residency: Patient resides in the U.S. or a U.S. territory.
- Clinical criteria: Patient has a clinically confirmed IRD eligible for the program.
- Family status: Patient has no first-degree relatives previously tested through the Program.
- Prior testing: Patient has not undergone an IRD panel of 32+ genes, WES, or WGS within the last 5 years.
- Prior results: Patient has not received an IRD-related molecular diagnosis from any previous testing.
- Registry requirement: Patient agrees to enroll in the My Retina Tracker Registry and allow results to be shared.
- Familial variant testing: Relatives of individuals with a positive or indeterminate Program result may qualify for no-cost targeted variant testing.
Workflow
How to use this program
- 1
Apply for Participation
Submit the provider application to the Foundation Fighting Blindness. Approval is required before you can order testing through the Program.
- 2
Create a Program Account
Set up your Program-specific account here. Ordering access will be granted after the Foundation processes your request.
- 3
Share Program Materials
Use the Program webform link provided by the Foundation to submit patient details. Patients receive study materials and consent forms via email.
- 4
Download Patient’s HIPAA Form
Once the patient signs electronically, you will receive the executed HIPAA release by email. Download and save it for the test requisition form.
- 5
Complete the TRF
Access the Program portal to enter clinical information, upload the HIPAA release, and select your genetic counseling preference—this choice cannot be changed later.
- 6
Determine Sample Collection
Collect the sample in clinic or request a kit be mailed to the patient. Label specimens with at least two identifiers. Deliveries are accepted Monday–Saturday.
- 7
Review Results and Counsel
Results are typically returned in about 21 days. Discuss results with the patient or coordinate post-test counseling through InformedDNA, based on your selection.
Billing overview
Program billing
For eligible patients, the sponsor has arrangements with the laboratory that may reduce or cover some or all of the patient's out-of-pocket cost. Actual cost and patient responsibility vary by program criteria. Refer to lab or sponsor materials for details.
Quality & privacy
Laboratory quality & data handling
Testing is performed by Prevention Genetics, a CLIA-certified laboratory (CLIA 52D2065132) and College of American Pathologists (CAP) certified laboratory (CAP 7185561). Your sample is processed using validated methods and quality controls to support reliable genetic results.
Your health information is handled under privacy and security practices that are intended to align with applicable regulations. For program- and lab-specific details, review the privacy information provided by the laboratory and sponsor.
FAQ
Frequently asked questions
How do I participate?
Providers must first apply to the Program through the Foundation Fighting Blindness. Once approved, you will receive access to the Program-specific ordering portal.
Which patients are eligible?
Eligible patients must reside in the U.S. or a U.S. territory, have a clinically confirmed IRD, and have no first-degree relatives tested through the Program. Patients must not have had a ≥32-gene IRD panel, exome sequencing, genome sequencing, or a prior IRD-related molecular diagnosis and must agree to join the My Retina Tracker Registry.
What is the enrollment workflow?
Providers must first apply for participation through the Foundation Fighting Blindness. Once approved, you will create a Program-specific account at the My Retina Tracker Program ordering portal. After access is granted, you will receive a link to the Program webform, which you will use to submit patient information and begin the enrollment process.
Where can samples be collected?
Samples can be collected in clinic or via a home collection kit mailed to the patient. All specimens must include at least two identifiers. Deliveries are accepted Monday–Saturday; holiday schedules apply.
What is the expected turnaround time?
Results are typically available about 21 days after the specimen and all required documentation are received.
Who provides genetic counseling?
Post-test genetic counseling is conducted either by you or by InformedDNA, depending on your selection on the requisition form. If you choose InformedDNA, they will contact the patient after results are available.
Can family members be tested?
Yes. Biological relatives of individuals who receive a positive or, in some cases, indeterminate Program result may qualify for no-cost familial variant testing through the Program.
See an issue with this program?